| 000 | 01664 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515052058.0 | ||
| 264 | 0 | _c20070130 | |
| 008 | 200701s 0 0 fre d | ||
| 022 | _a0003-3928 | ||
| 024 | 7 |
_a10.1016/j.ancard.2005.09.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoulé, S | |
| 245 | 0 | 0 |
_a[Acute myocardial infarction: what is new?]. _h[electronic resource] |
| 260 |
_bAnnales de cardiologie et d'angeiologie _cNov 2005 |
||
| 300 |
_a344-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xmethods |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdiagnosis |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGongora, A | |
| 700 | 1 | _aRandriamora, M | |
| 700 | 1 | _aAdala, D | |
| 700 | 1 | _aCourteaux, C | |
| 700 | 1 | _aTaghipour, K | |
| 700 | 1 | _aRifaï, A | |
| 700 | 1 | _aBearez, E | |
| 700 | 1 | _aHannebicque, G | |
| 773 | 0 |
_tAnnales de cardiologie et d'angeiologie _gvol. 54 _gno. 6 _gp. 344-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ancard.2005.09.007 _zAvailable from publisher's website |
| 999 |
_c16751343 _d16751343 |
||